[{"address1": "3052 Orchard Drive", "city": "San Jose", "state": "CA", "zip": "95134", "country": "United States", "phone": "669 231 8200", "website": "https://www.outsetmedical.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.", "fullTimeEmployees": 480, "companyOfficers": [{"maxAge": 1, "name": "Ms. Leslie L. Trigg", "age": 52, "title": "President, CEO & Chairman", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 1220070, "exercisedValue": 3560719, "unexercisedValue": 544376}, {"maxAge": 1, "name": "Mr. Nabeel  Ahmed", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 613331, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Oliver  Racine", "age": 41, "title": "Chief Technology Officer", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 528951, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John L. Brottem", "age": 48, "title": "General Counsel & Secretary", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 547095, "exercisedValue": 152206, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Nash", "age": 34, "title": "Senior Vice President of Operations and R&D", "yearBorn": 1989, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James S. Mazzola", "title": "Head of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nicole  Shannon", "title": "Director of Marketing Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Aragon M.D.", "title": "Chief Medical  Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Gordon M.S.", "age": 66, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1714521600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.52, "open": 3.52, "dayLow": 3.47, "dayHigh": 3.62, "regularMarketPreviousClose": 3.52, "regularMarketOpen": 3.52, "regularMarketDayLow": 3.47, "regularMarketDayHigh": 3.62, "beta": 1.841, "forwardPE": -3.0854702, "volume": 749333, "regularMarketVolume": 749333, "averageVolume": 1333506, "averageVolume10days": 2936060, "averageDailyVolume10Day": 2936060, "bid": 3.58, "ask": 3.63, "bidSize": 100, "askSize": 400, "marketCap": 186717856, "fiftyTwoWeekLow": 1.92, "fiftyTwoWeekHigh": 24.13, "priceToSalesTrailing12Months": 1.4928232, "fiftyDayAverage": 2.5659, "twoHundredDayAverage": 6.0071, "currency": "USD", "enterpriseValue": 162307776, "profitMargins": -1.34933, "floatShares": 50832750, "sharesOutstanding": 51722400, "sharesShort": 9448174, "sharesShortPriorMonth": 8360312, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.18270001, "heldPercentInsiders": 0.01805, "heldPercentInstitutions": 0.99651, "shortRatio": 9.94, "shortPercentOfFloat": 0.2142, "bookValue": 1.803, "priceToBook": 2.0022185, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -168770000, "trailingEps": -3.36, "forwardEps": -1.17, "pegRatio": -0.08, "enterpriseToRevenue": 1.298, "enterpriseToEbitda": -1.032, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "OM", "underlyingSymbol": "OM", "shortName": "Outset Medical, Inc.", "longName": "Outset Medical, Inc.", "firstTradeDateEpochUtc": 1600176600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bfbebc07-8222-3b0f-8f99-1f1405ec537d", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.61, "targetHighPrice": 9.0, "targetLowPrice": 3.0, "targetMeanPrice": 5.64, "targetMedianPrice": 6.0, "recommendationMean": 2.4, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 226919008, "totalCashPerShare": 4.387, "ebitda": -157311008, "totalDebt": 202508992, "quickRatio": 5.198, "currentRatio": 6.422, "totalRevenue": 125077000, "debtToEquity": 217.284, "revenuePerShare": 2.496, "returnOnAssets": -0.28776, "returnOnEquity": -1.0906501, "freeCashflow": -74899248, "operatingCashflow": -132529000, "revenueGrowth": -0.158, "grossMargins": 0.24614, "ebitdaMargins": -1.25771, "operatingMargins": -1.31042, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-19"}]